EVH logo

Evolent Health (EVH) EBITDA

Annual EBITDA

$80.06 M
+$104.84 M+423.00%

December 31, 2024

Summary

Performance

1-Year Change

+423%

3-Year Change

+43.83%

5-Year Change

+131.45%

15-Year Change

+298.16%

EVH EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

86.72%
EVH annual EBITDA is higher than 86.72% of companies in Healthcare sector

High & Low

All-time High

$350.45 M
EVH annual EBITDA is currently -77.16% below its historical high of $350.45 million

3-Year Low

-$24.79 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
EVH previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
EVH next annual earnings announcement has not yet been scheduled

OtherEVHprofitabilitymetrics:

Annual Revenue

$2.55 B
EVH annual revenue is $2.55 billion

Annual Net Income

-$61.62 M
EVH annual net profit is -$61.62 million

Annual EBIT

-$38.31 M
EVH annual earnings before interest & taxes is -$38.31 million

Annual EPS

-$0.81
EVH annual earnings per share is -$0.81

Quarterly EBITDA

$12.09 M
+$138.00 K+1.15%

December 31, 2024

Summary

Performance

3-Month Change

+1.15%

1-Year Change

+1.15%

3-Year Change

+1.15%

5-Year Change

+1.15%

EVH Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

82.95%
EVH quarterly EBITDA is higher than 82.95% of companies in Healthcare sector

High & Low

All-time High

$375.20 M
EVH quarterly EBITDA is currently -96.78% below its historical high of $375.20 million

3-Year Low

-$46.00 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
EVH previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 9, 2025
EVH next earnings announcement is scheduled for May 9, 2025

OtherEVHprofitabilitymetrics:

Quarterly Revenue

$646.54 M
EVH quarterly revenue is $646.54 million

Quarterly Net Income

-$22.80 M
EVH quarterly net profit is -$22.80 million

Quarterly EBIT

-$17.20 M
EVH quarterly earnings before interest & taxes is -$17.20 million

Quarterly EPS

-$0.27
EVH quarterly earnings per share is -$0.27

TTM EBITDA

$80.06 M
+$18.32 M+29.67%

December 31, 2024

Summary

Performance

3-Month Change

+29.67%

1-Year Change

+29.67%

3-Year Change

+29.67%

5-Year Change

+29.67%

EVH TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

85.93%
EVH TTM EBITDA is higher than 85.93% of companies in Healthcare sector

High & Low

All-time High

$350.45 M
EVH TTM EBITDA is currently -77.16% below its historical high of $350.45 million

3-Year Low

-$40.16 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
EVH previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 9, 2025
EVH next earnings announcement is scheduled for May 9, 2025

OtherEVHprofitabilitymetrics:

TTM Revenue

$2.55 B
EVH TTM revenue is $2.55 billion

TTM Net Income

-$61.62 M
EVH TTM net profit is -$61.62 million

TTM EBIT

-$38.31 M
EVH TTM earnings before interest & taxes is -$38.31 million

TTM EPS

-$0.82
EVH TTM earnings per share is -$0.82

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

$80.06 M
EVH annual EBITDA is $80.06 million

Annual Net Income

-$61.62 M
EVH annual net profit is -$61.62 million

Annual Interest Expense

$24.72 M
EVH annual interest expense is $24.72 million

Annual Income Tax

-$1.41 M
EVH annual income tax is -$1.41 million

Annual D&A

$118.37 M
EVH annual depreciation & amortization is $118.37 million

EVH EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+423.0%+1.1%+29.7%
3 y3 years+43.8%+1.1%+29.7%
5 y5 years+131.4%+1.1%+29.7%

EVH EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+423.0%-67.5%+126.3%at high+299.3%
5 y5-yearat high+131.4%-67.5%+105.9%at high+117.5%
alltimeall time-77.2%+131.4%-96.8%+105.9%-77.2%+117.5%

Evolent Health EBITDA History

DateAnnualQuarterlyTTM
Dec 2024
$80.06 M(-423.0%)
$12.09 M(+1.2%)
$80.06 M(+29.7%)
Sep 2024
-
$11.96 M(-67.9%)
$61.74 M(-6.4%)
Jun 2024
-
$37.22 M(+98.2%)
$65.92 M(+64.8%)
Mar 2024
-
$18.79 M(-401.7%)
$40.00 M(-261.4%)
Dec 2023
-$24.79 M(-219.8%)
-$6.23 M(-138.6%)
-$24.79 M(+862.5%)
Sep 2023
-
$16.14 M(+42.9%)
-$2.58 M(-93.6%)
Jun 2023
-
$11.30 M(-124.6%)
-$40.16 M(+4.3%)
Mar 2023
-
-$46.00 M(-387.8%)
-$38.51 M(-286.1%)
Dec 2022
$20.69 M(-62.8%)
$15.98 M(-174.5%)
$20.69 M(-28.2%)
Sep 2022
-
-$21.44 M(-265.6%)
$28.83 M(-50.9%)
Jun 2022
-
$12.95 M(-1.9%)
$58.69 M(+1.3%)
Mar 2022
-
$13.20 M(-45.3%)
$57.91 M(+3.8%)
Dec 2021
$55.66 M(-123.1%)
$24.12 M(+186.5%)
$55.82 M(+24.0%)
Sep 2021
-
$8.42 M(-30.8%)
$45.03 M(+103.0%)
Jun 2021
-
$12.17 M(+9.6%)
$22.19 M(-112.8%)
Mar 2021
-
$11.11 M(-16.7%)
-$173.84 M(-27.8%)
Dec 2020
-$240.74 M(-5.4%)
$13.33 M(-192.4%)
-$240.74 M(-47.5%)
Sep 2020
-
-$14.42 M(-92.2%)
-$458.13 M(+1.5%)
Jun 2020
-
-$183.85 M(+229.5%)
-$451.26 M(+61.7%)
Mar 2020
-
-$55.80 M(-72.7%)
-$279.00 M(+9.6%)
Dec 2019
-$254.52 M
-$204.06 M(+2603.2%)
-$254.52 M(+404.7%)
Sep 2019
-
-$7.55 M(-34.9%)
-$50.43 M(+14.4%)
DateAnnualQuarterlyTTM
Jun 2019
-
-$11.59 M(-63.0%)
-$44.09 M(+38.9%)
Mar 2019
-
-$31.32 M(<-9900.0%)
-$31.76 M(+664.8%)
Dec 2018
-$4.15 M(-89.7%)
$27.00 K(-102.2%)
-$4.15 M(-60.9%)
Sep 2018
-
-$1.22 M(-262.2%)
-$10.61 M(-32.2%)
Jun 2018
-
$749.00 K(-120.2%)
-$15.64 M(-45.9%)
Mar 2018
-
-$3.71 M(-42.3%)
-$28.94 M(-28.4%)
Dec 2017
-$40.40 M(-81.6%)
-$6.43 M(+3.0%)
-$40.40 M(-34.4%)
Sep 2017
-
-$6.25 M(-50.2%)
-$61.56 M(-8.9%)
Jun 2017
-
-$12.55 M(-17.3%)
-$67.60 M(+5.9%)
Mar 2017
-
-$15.18 M(-45.0%)
-$63.81 M(-71.0%)
Dec 2016
-$220.06 M(-162.8%)
-$27.59 M(+124.6%)
-$220.06 M(-220.4%)
Sep 2016
-
-$12.29 M(+40.3%)
$182.73 M(+1.1%)
Jun 2016
-
-$8.76 M(-94.9%)
$180.82 M(+1.0%)
Mar 2016
-
-$171.43 M(-145.7%)
$179.03 M(-48.9%)
Dec 2015
$350.45 M(>+9900.0%)
$375.20 M(-2744.1%)
$350.45 M(-1516.3%)
Sep 2015
-
-$14.19 M(+34.4%)
-$24.75 M(+134.4%)
Jun 2015
-
-$10.55 M(<-9900.0%)
-$10.55 M(<-9900.0%)
Mar 2015
-
$0.00(0.0%)
$0.00(-100.0%)
Dec 2014
$0.00(-100.0%)
$0.00(0.0%)
-$10.99 M(0.0%)
Sep 2014
-
$0.00(0.0%)
-$10.99 M(0.0%)
Jun 2014
-
$0.00(-100.0%)
-$10.99 M(0.0%)
Mar 2014
-
-$10.99 M
-$10.99 M
Dec 2013
-$19.95 M
-
-

FAQ

  • What is Evolent Health annual EBITDA?
  • What is the all time high annual EBITDA for Evolent Health?
  • What is Evolent Health annual EBITDA year-on-year change?
  • What is Evolent Health quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Evolent Health?
  • What is Evolent Health quarterly EBITDA year-on-year change?
  • What is Evolent Health TTM EBITDA?
  • What is the all time high TTM EBITDA for Evolent Health?
  • What is Evolent Health TTM EBITDA year-on-year change?

What is Evolent Health annual EBITDA?

The current annual EBITDA of EVH is $80.06 M

What is the all time high annual EBITDA for Evolent Health?

Evolent Health all-time high annual EBITDA is $350.45 M

What is Evolent Health annual EBITDA year-on-year change?

Over the past year, EVH annual EBITDA has changed by +$104.84 M (+423.00%)

What is Evolent Health quarterly EBITDA?

The current quarterly EBITDA of EVH is $12.09 M

What is the all time high quarterly EBITDA for Evolent Health?

Evolent Health all-time high quarterly EBITDA is $375.20 M

What is Evolent Health quarterly EBITDA year-on-year change?

Over the past year, EVH quarterly EBITDA has changed by +$138.00 K (+1.15%)

What is Evolent Health TTM EBITDA?

The current TTM EBITDA of EVH is $80.06 M

What is the all time high TTM EBITDA for Evolent Health?

Evolent Health all-time high TTM EBITDA is $350.45 M

What is Evolent Health TTM EBITDA year-on-year change?

Over the past year, EVH TTM EBITDA has changed by +$18.32 M (+29.67%)